Source: Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Guy Meyer, Stavros Konstantinides. Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?. Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Should thrombolysis and sildenafil be given in the acute management of patients with large pulmonary embolism? An assessment of the short and long-term outcomes. Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Early discharge of patients with pulmonary embolism: feasibility of domicillary anticoagulation Source: Eur Respir J 2003; 22: Suppl. 45, 219s Year: 2003 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism Source: Eur Respir J 2013; 41: 588-592 Year: 2013 Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Presence of bronchopulmonary shunting is an independent risk factor for recurrence of hemoptysis following bronchial artery embolization in younger patients with bronchiectasis: a long-term outcome Source: International Congress 2019 – Highlights in lung function and chronic cough Year: 2019 Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review Source: Eur Respir J 2009; 33: 1148-1155 Year: 2009 Recommended uses for indefinite secondary prophylaxis in patients with pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Efficacy of a 12 months oral sildenafil treatment in patients with severe pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 660s Year: 2006 A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 A case-control study on direct oral anticoagulants versus warfarin for acute pulmonary embolism in obese patients Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli Source: ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020 Year: 2021 The evaluation of medication adherence in patients with pulmonary thromboembolism Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018 Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019